DOCS logo

Doximity Inc. Class A (DOCS)

$31.11

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on DOCS

Market cap

$5.55B

EPS

0.71

P/E ratio

36.3

Price to sales

8.29

Dividend yield

--

Beta

1.291592

Price on DOCS

Previous close

$32.77

Today's open

$32.37

Day's range

$30.71 - $32.54

52 week range

$17.15 - $51.85

Profile about DOCS

CEO

Jeff Tangney

Employees

880

Headquarters

San Francisco, CA

Exchange

New York Stock Exchange

Shares outstanding

178409454

Issue type

Common Stock

DOCS industries and sectors

Healthcare

Healthcare Providers & Services

News on DOCS

Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

New class action for Doximity (DOCS) urges investors to seek recovery for alleged securities fraud violations – lead plaintiff deadline of 11/16/2026

news source

GlobeNewsWire • Nov 16, 2026

news preview

DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law

LOS ANGELES--(BUSINESS WIRE)---- $DOCS--DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law.

news source

Business Wire • Nov 16, 2026

news preview

Doximity, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - DOCS

NEW YORK, Nov. 16, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "the Company") (NYSE: DOCS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purchased shares of DOCS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointments.

news source

PRNewsWire • Nov 17, 2026

news preview

DOCS Expands Clinical AI Tools Across Three Major U.S. Health Systems

Doximity expands its AI tools across three major healthcare institutions, bringing clinical decision support and documentation into existing workflows.

news source

Zacks Investment Research • Nov 16, 2026

news preview

DEADLINE ALERT for Doximity, Inc. (DOCS), Better Home & Finance Holding Company (BETR), Honeywell Aerospace, Inc. (HONA) and Tigo Energy, Inc. (TYGO): The Law Offices of Frank R. Cruz Reminds Investors of Lead Plaintiff Deadlines in Securities Fraud Class Actions

Investors in Doximity, Inc., Better Home & Finance Holding Company, Honeywell Aerospace, Inc., and Tigo Energy, Inc. have upcoming deadlines to seek lead plaintiff appointment in pending securities class actions Investors in Doximity, Inc., Better Home & Finance Holding Company, Honeywell Aerospace, Inc., and Tigo Energy, Inc. have upcoming deadlines to seek lead plaintiff appointment in pending securities class actions

news source

GlobeNewsWire • Nov 16, 2026

news preview

DOXIMITY DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action – DOCS

NEW YORK, Nov. 15, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026, both dates inclusive (the “Class Period”), of the important November 16, 2026 lead plaintiff deadline.

news source

GlobeNewsWire • Nov 16, 2026

news preview

DOXIMITY DEADLINE: ROSEN, A TOP-RANKED LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action - DOCS

New York, New York--(Newsfile Corp. - November 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Doximity, Inc. (NYSE: DOCS) between August 8, 2024 and May 13, 2026, both dates inclusive (the "Class Period"), of the important November 16, 2026 lead plaintiff deadline. SO WHAT: If you purchased Doximity common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

news source

Newsfile Corp • Nov 14, 2026

news preview

DOXIMITY DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Urges Doximity, Inc. Investors to Contact the Firm Before November 16th Lead Plaintiff Deadline

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Doximity (DOCS) To Contact Him Directly To Discuss Their Options

news source

GlobeNewsWire • Nov 13, 2026

news preview

Doximity to Provide New Clinical AI Tools Across NewYork-Presbyterian, Columbia University and Weill Cornell Medicine

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Doximity, the leading digital platform for U.S. medical professionals, NewYork-Presbyterian, Columbia University and Weill Cornell Medicine today announced that Doximity will provide clinical staff at all three academic healthcare institutions with additional AI-powered clinical decision support and scribe tools.Through Doximity, NewYork-Presbyterian, Columbia and Weill Cornell Medicine clinician teams will have access to Doximity's clinical AI suite to.

news source

Business Wire • Nov 13, 2026

news preview

Deadline Alert: Doximity, Inc. Investors Have Until November 16, 2026 to Seek Lead Plaintiff Role in Securities Fraud Class Action, Glancy Prongay Wolke & Rotter LLP Reminds Investors

Class action covers investors who bought Doximity, Inc. securities between August 8, 2024 and May 13, 2026; complaint alleges the company failed to disclose material adverse facts Class action covers investors who bought Doximity, Inc. securities between August 8, 2024 and May 13, 2026; complaint alleges the company failed to disclose material adverse facts

news source

GlobeNewsWire • Nov 12, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Doximity Inc. Class A

Open an M1 investment account to buy and sell Doximity Inc. Class A commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in DOCS on M1